| |
| |
| Table of Antidotes in Depth | |
| |
| |
| Contributors | |
| |
| |
| Preface | |
| |
| |
| Acknowledgments | |
| |
| |
| |
| Historical Principles and Perspectives | |
| |
| |
| |
| |
| Toxicologic Plagues and Disasters in History | |
| |
| |
| |
| |
| the General Approach to Medical Toxicology | |
| |
| |
| |
| Initial Evaluation of the Patient: Vital Signs and Toxic Syndromes | |
| |
| |
| |
| |
| Principles of Managing the Acutely Poisoned or Overdosed Patient | |
| |
| |
| |
| |
| Diagnostic Imaging | |
| |
| |
| |
| |
| Laboratory Principles | |
| |
| |
| |
| |
| Techniques Used to Prevent Gastrointestinal Absorption | |
| |
| |
| |
| |
| Syrup of Ipecac | |
| |
| |
| |
| |
| Activated Charcoal | |
| |
| |
| |
| |
| Whole-Bowel Irrigation and Other Intestinal Evacuants | |
| |
| |
| |
| |
| Pharmacokinetic and Toxicokinetic Principles | |
| |
| |
| |
| |
| Principles and Techniques Applied to Enhance Elimination | |
| |
| |
| |
| |
| Use of The Intensive Care Unit | |
| |
| |
| |
| |
| the Fundamental Principles of Medical Toxicology | |
| |
| |
| |
| Biochemical and Molecular Basis | |
| |
| |
| |
| Chemical Principles | |
| |
| |
| |
| |
| Biochemical and Metabolic Principles | |
| |
| |
| |
| |
| Neurotraansmitters and Neuromodulators | |
| |
| |
| |
| |
| Withdrawal Principles | |
| |
| |
| |
| |
| Pathophysiologic Basis: Organ Systems | |
| |
| |
| |
| Thermoregulatory Principles | |
| |
| |
| |
| |
| Fluid, Electrolyte, and Acid-Based Principles | |
| |
| |
| |
| |
| Psychiatric Principles | |
| |
| |
| |
| |
| Neurologic Principles | |
| |
| |
| |
| |
| Ophthalmic Principles | |
| |
| |
| |
| |
| Otolaryngologic Principles | |
| |
| |
| |
| |
| Respiratory Principles | |
| |
| |
| |
| |
| Electrophysiologic and Electrocardiographic Principles | |
| |
| |
| |
| |
| Hemodynamic Principles | |
| |
| |
| |
| |
| Hematologic Principles | |
| |
| |
| |
| |
| Gastrointestinal Principles | |
| |
| |
| |
| |
| Hepatic Principles | |
| |
| |
| |
| |
| Renal Principles | |
| |
| |
| |
| |
| Genitourinary Principles | |
| |
| |
| |
| |
| Dermatologic Principles | |
| |
| |
| |
| |
| Special Populations | |
| |
| |
| |
| Reproductive and Perinatal Principles | |
| |
| |
| |
| |
| Pediatric Principles | |
| |
| |
| |
| |
| Geriatric Principles | |
| |
| |
| |
| |
| Postmortem Toxicology | |
| |
| |
| |
| |
| Organ Procurement from Poisoned Patients | |
| |
| |
| |
| |
| the Clinical Basis of Medical Toxicology | |
| |
| |
| |
| Case Studies | |
| |
| |
| |
| Analgesics and Antiinflammatory Medications | |
| |
| |
| |
| Acetaminophen | |
| |
| |
| |
| |
| N-Acetylcysteine | |
| |
| |
| |
| |
| Salicylates | |
| |
| |
| |
| |
| Sodium Bicarbonate | |
| |
| |
| |
| |
| Nonsteroidal Antiinflammatory Drugs | |
| |
| |
| |
| |
| Colchicine, Podophyllin, and the Vinca Alkoloids | |
| |
| |
| |
| |
| Intrathecal Administration of Xenobiotics | |
| |
| |
| |
| |
| Opioids | |
| |
| |
| |
| |
| Opioid Antagonists | |
| |
| |
| |
| |
| Foods, Dietary and Nutritional Agents | |
| |
| |
| |
| Dieting Agents and Regimens | |
| |
| |
| |
| |
| Iron | |
| |
| |
| |
| |
| Deferoxamine | |
| |
| |
| |
| |
| Vitamins | |
| |
| |
| |
| |
| Essential Oils | |
| |
| |
| |
| |
| Herbal Preparations | |
| |
| |
| |
| |
| Athletic Performance Enhancers | |
| |
| |
| |
| |
| Food Poisoning | |
| |
| |
| |
| |
| Botulism | |
| |
| |
| |
| |
| Botulinum Antitoxin | |
| |
| |
| |
| |
| Pharmaceuticals | |
| |
| |
| |
| Anticonvulsants | |
| |
| |
| |
| |
| L-Carnitine | |
| |
| |
| |
| |
| Antidiabetics and Hypoglycemics | |
| |
| |
| |
| |
| Dextrose | |
| |
| |
| |
| |
| Octreotide | |
| |
| |
| |
| |
| Thyroid and Antithyroid Medications | |
| |
| |
| |
| |
| Antihistamines and Decongestants | |
| |
| |
| |
| |
| Physostigmine Salicylate | |
| |
| |
| |
| |
| Antimigraine Medications | |
| |
| |
| |
| |
| Antineoplastics Overview | |
| |
| |
| |
| |
| Antineoplastics: Methotrexate | |
| |
| |
| |
| |
| Leucovorin (Folinic Acid) and Folic Acid | |
| |
| |
| |
| |
| Glucarpidase, (Carboxypeptidas G2) | |
| |
| |
| |
| |
| Extravasation of Xenobotics | |
| |
| |
| |
| |
| Miscellaneous Antineoplastics | |
| |
| |
| |
| |
| Pharmaceutical Additives | |
| |
| |
| |
| |
| Antimicrobials | |
| |
| |
| |
| Antibacterials, Antifungals, and Antivirals | |
| |
| |
| |
| |
| Antituberculous Medications | |
| |
| |
| |
| |
| Antimalarials | |
| |
| |
| |
| |
| Cardiopulmonary Medications | |
| |
| |
| |
| Anticoagulants | |
| |
| |
| |
| |
| Vitamin K | |
| |
| |
| |
| |
| Protamine | |
| |
| |
| |
| |
| Calcium Channel Blockers | |
| |
| |
| |
| |
| Insulin-Eyglycemia Therapy | |
| |
| |
| |
| |
| B-Adrenergic Antagonists | |
| |
| |
| |
| |
| Glucagon | |
| |
| |
| |
| |
| Other Antihypertensives | |
| |
| |
| |
| |
| Antidysrhythmics | |
| |
| |
| |
| |
| Cardioactive Steroids | |
| |
| |
| |
| |
| Digoxin-Specific Antibody Fragments | |
| |
| |
| |
| |
| Methylxanthines and Selective B2 Adrenergic Agonists | |
| |
| |
| |
| |
| Anesthetics and Related Medications | |
| |
| |
| |
| Local Anesthetics | |
| |
| |
| |
| |
| Intravenous Fat Emulsions | |
| |
| |
| |
| |
| Inhalational Anesthetics | |
| |
| |
| |
| |
| Neuromuscular Blockers | |
| |
| |
| |
| |
| Dantrolene Sodium | |
| |
| |
| |
| |
| Psychotropic Medications | |
| |
| |
| |
| Antipsychotics | |
| |
| |
| |
| |
| Lithium | |
| |
| |
| |
| |
| Monoamine Oxidase Inhibitors | |
| |
| |
| |
| |
| Serotonin Reuptake Inhibitors and Atypical Antidepressants | |
| |
| |
| |
| |
| Cyclic Antidepressants | |
| |
| |
| |
| |
| Sedative-Hynotics | |
| |
| |
| |
| |
| Flumazenil | |
| |
| |
| |
| |
| Substances of Abuse | |
| |
| |
| |
| Amphetamines | |
| |
| |
| |
| |
| Cocaine | |
| |
| |
| |
| |
| Internal Concealment of Xenobiotics | |
| |
| |
| |
| |
| Benzodiazepines | |
| |
| |
| |
| |
| Ethanol | |
| |
| |
| |
| |
| Thiamine Hydrochloride | |
| |
| |
| |
| |
| Ethanol Withdrawal | |
| |
| |
| |
| |
| Disulfiram and Disulfiram-Like Reactions | |
| |
| |
| |
| |
| Y-Hydroxybutyric Acid | |
| |
| |
| |
| |
| Inhalants | |
| |
| |
| |
| |
| Hallucinogens | |
| |
| |
| |
| |
| Cannabinoids | |
| |
| |
| |
| |
| Nicotine | |
| |
| |
| |
| |
| Phencyclidine and Ketamine | |
| |
| |
| |
| |
| Aluminum | |
| |
| |
| |
| |
| Metals | |
| |
| |
| |
| Antimony | |
| |
| |
| |
| |
| Arsenic | |
| |
| |
| |
| |
| Dimercaprol (British Anti-Lewisite or Bal) | |
| |
| |
| |
| |
| Bismuth | |
| |
| |
| |
| |
| Cadmium | |
| |
| |
| |
| |
| Chromium | |
| |
| |
| |
| |
| Cobalt | |
| |
| |
| |
| |
| Copper | |
| |
| |
| |
| |
| Lead | |
| |
| |
| |
| |
| Succimer (2,3-Dimercaptosuccinic Acid) | |
| |
| |
| |
| |
| Edetate Calcium Disodium (CaNa2EDTA) | |
| |
| |
| |
| |
| Manganese | |
| |
| |
| |
| |
| Mercury | |
| |
| |
| |
| |
| Nickel | |
| |
| |
| |
| |
| Selenium | |
| |
| |
| |
| |
| Silver | |
| |
| |
| |
| |
| Thallium | |
| |
| |
| |
| |
| Prussian Blue | |
| |
| |
| |
| |
| Zinc | |
| |
| |
| |
| |
| Household Products | |
| |
| |
| |
| Antiseptics, Disinfectants, and Sterilants | |
| |
| |
| |
| |
| Camphor and Moth Repellents | |
| |
| |
| |
| |
| Caustics | |
| |
| |
| |
| |
| Hydrofluoric Acid and Fluorides | |
| |
| |
| |
| |
| Calcium | |
| |
| |
| |
| |
| Hydrocarbons | |
| |
| |
| |
| |
| Toxic Alcohols | |
| |
| |
| |
| |
| Diethylene Glycol | |
| |
| |
| |
| |
| Fomepizole | |
| |
| |
| |
| |
| Ethanol | |
| |
| |
| |
| |
| Pesticides | |
| |
| |
| |
| Pesticides: An Overview with a Focus on Principles and Rodenticides | |
| |
| |
| |
| |
| Barium | |
| |
| |
| |
| |
| Sodium Monofluoroacetate and Fluroacetamide | |
| |
| |
| |
| |
| Phosphorus | |
| |
| |
| |
| |
| Strychnine | |
| |
| |
| |
| |
| Insecticides: Organic Phosphorus Compounds and Carbamates | |
| |
| |
| |
| |
| Pralidoxmine | |
| |
| |
| |
| |
| Atropine | |
| |
| |
| |
| |
| Insecticides: Organic Chlorines | |
| |
| |
| |
| |
| Herbicides | |
| |
| |
| |
| |
| Methyl Bromide and Other Fumigants | |
| |
| |
| |
| |
| Natural Toxins and Envenomations | |
| |
| |
| |
| Mushrooms | |
| |
| |
| |
| |
| Plants | |
| |
| |
| |
| |
| Arthropods | |
| |
| |
| |
| A35 | |
| |
| |
| |
| |
| Marine Envenomations | |
| |
| |
| |
| |
| Snakes and Other Reptiles | |
| |
| |
| |
| A36 | |
| |
| |
| |
| |
| Occupational and Environmental Toxins | |
| |
| |
| |
| Industrial Poisoning: Information and Control | |
| |
| |
| |
| |
| Nanotoxicology | |
| |
| |
| |
| |
| Simple Asphyxiants and Pulmonary Irritants | |
| |
| |
| |
| |
| Carbon Monoxide | |
| |
| |
| |
| |
| Hyperbaric Oxygen | |
| |
| |
| |
| |
| Cyanide Andhydrogen Sulfide | |
| |
| |
| |
| |
| Sodium and Amyl Nitrites | |
| |
| |
| |
| |
| Sodium Thiosulfate | |
| |
| |
| |
| |
| Hydroxocobalamin | |
| |
| |
| |
| |
| Methemoglobin Inducers | |
| |
| |
| |
| |
| Methylene Blue | |
| |
| |
| |
| |
| Smoke Inhalation | |
| |
| |
| |
| |
| Disaster Preparedness | |
| |
| |
| |
| Risk Assessment and Risk Communications | |
| |
| |
| |
| |
| Hazmat Incident Response | |
| |
| |
| |
| |
| Chemical Weapons | |
| |
| |
| |
| |
| Biological Weapons | |
| |
| |
| |
| |
| Radiation | |
| |
| |
| |
| |
| Potassium Iodide | |
| |
| |
| |
| |
| Pentetic Acid (Dtpa) or Pentetate (Zinc or Calcium) Trisodium | |
| |
| |
| |
| |
| Poison Centers and Epidemiology | |
| |
| |
| |
| Poison Prevention and Education | |
| |
| |
| |
| |
| Poison Centers and Poison Epidemiology | |
| |
| |
| |
| |
| International Perspectives on Toxicology | |
| |
| |
| |
| |
| Principles of Epidemiology and Research Design | |
| |
| |
| |
| |
| Adverse Drug Events and Postmarketing Surveillance | |
| |
| |
| |
| |
| Medication Safety and Adverse Drug Events | |
| |
| |
| |
| |
| Risk Management and Legal Principles | |
| |
| |
| |
| Index | |